Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
PACS Group Inc ( (PACS) ) has shared an announcement.
On April 24, 2026, PACS Group’s board named longtime public-company finance executive Carey Hendrickson as chief financial officer, effective April 27, 2026, as part of a planned transition from co-founder and interim CFO Mark Hancock, who will retire as an executive officer on June 30, 2026 but remain vice chairman of the board. Hendrickson’s compensation package includes a $475,000 base salary, eligibility for a sizable annual bonus, and a three-year vesting restricted stock unit grant intended to align his incentives with long-term company performance.
The move caps Hancock’s tenure as PACS’s first CFO, during which the company expanded from two post-acute facilities in 2013 to 323 locations across 17 states and achieved $5.29 billion in revenue in 2025, alongside a successful NYSE listing in April 2024. By keeping Hancock on the board while installing Hendrickson—whose experience spans healthcare, senior living, and media CFO roles—as principal financial officer, PACS signals to investors that it is balancing continuity of its founding vision with experienced financial leadership to support its next phase of growth in the post-acute care sector.
The most recent analyst rating on (PACS) stock is a Buy with a $44.00 price target. To see the full list of analyst forecasts on PACS Group Inc stock, see the PACS Stock Forecast page.
Spark’s Take on PACS Stock
According to Spark, TipRanks’ AI Analyst, PACS is a Neutral.
The score is held back primarily by financial risk signals—especially the reported 2025 collapse to zero operating/free cash flow and a debt-heavy balance sheet—despite strong growth and improved profitability. The latest earnings call offsets some of this with solid 2026 guidance and stated low net leverage, while technicals and valuation are both only moderate.
To see Spark’s full report on PACS stock, click here.
More about PACS Group Inc
PACS Group, Inc., headquartered in Salt Lake City, Utah, operates one of the largest post-acute healthcare platforms in the United States, investing in and supporting post-acute care facilities, professionals, and ancillary services. Founded in 2013, its independent subsidiaries run more than 320 post-acute and senior living facilities across 17 states, serving over 31,700 patients daily and generating $5.29 billion in revenue in 2025, with a mission to transform the quality and leadership of post-acute care nationwide.
Co-founded by Mark Hancock and Chairman and CEO Jason Murray, PACS has expanded from two facilities in San Diego to 323 locations, reflecting rapid, acquisition-driven growth that culminated in a New York Stock Exchange listing in April 2024. The company’s scale, growth trajectory, and focus on disciplined balance sheet management position it as a major consolidator in the fragmented U.S. post-acute care market, with governance continuity supported by Hancock’s ongoing role as vice chairman after his executive retirement.
On April 24, 2026, PACS Group’s board appointed veteran finance executive Carey Hendrickson as chief financial officer, effective April 27, 2026, succeeding co-founder Mark Hancock, who plans to retire as an executive officer on June 30, 2026 while remaining vice chairman of the board. Hendrickson, whose background includes CFO roles at U.S. Physical Therapy and senior living operator Capital Senior Living, will serve as principal financial officer under an offer letter that provides a $475,000 base salary, a substantial incentive bonus opportunity, and a multi-year restricted stock unit grant designed to align his interests with shareholders.
The leadership transition formalizes succession planning at a company that has seen a more than 160-fold increase in facilities since its founding and underscores management’s focus on continuity following PACS’s 2024 IPO and Hancock’s interim CFO stint beginning in September 2025. With Hancock retaining a board seat and Hendrickson bringing nearly four decades of public-company finance experience in healthcare and related sectors, investors and other stakeholders are likely to view the move as reinforcing financial discipline and strategic stability at a rapidly scaling post-acute care platform.
Average Trading Volume: 885,597
Technical Sentiment Signal: Strong Buy
Current Market Cap: $5.57B
For a thorough assessment of PACS stock, go to TipRanks’ Stock Analysis page.